4//SEC Filing
Kane William P Jr 4
Accession 0000950170-24-015972
CIK 0001771917other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:53 PM ET
Size
6.0 KB
Accession
0000950170-24-015972
Insider Transaction Report
Form 4
Kane William P Jr
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2024-02-13+10,306→ 10,306 total→ Common Stock (10,306 underlying)
Footnotes (1)
- [F1]Reflects the annual equity award to the reporting person under the Karuna Therapeutics, Inc. 2019 Stock Option and Incentive Plan. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, at the effective time of the proposed merger transaction among the Issuer, Bristol-Myers Squibb Company and Miramar Merger Sub Inc., this RSU award will convert into a cash award equal to the product of (i) the total number of shares of the Issuer's common stock subject to this RSU award immediately prior to such effective time, and (ii) $330. The RSUs or, after such conversion, the cash award, shall vest annually in four equal installments on each of February 13, 2025, February 13, 2026, February 13, 2027 and February 13, 2028, subject to the reporting person's continued service through each such vesting date.
Documents
Issuer
Karuna Therapeutics, Inc.
CIK 0001771917
Entity typeother
Related Parties
1- filerCIK 0001813937
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:53 PM ET
- Size
- 6.0 KB